Epizyme, Inc. Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Epizyme, Inc. for June 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2020 | EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controlle ... | Sell | S | 16.15 | 317 | 5,120 | 4,838 | 5.2 K to 4.8 K (-6.15 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controlle ... | Grant | A | 0.00 | 1,050 | 0 | 5,155 | 4.1 K to 5.2 K (+25.58 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | S | 16.15 | 4,773 | 77,084 | 250,098 | 254.9 K to 250.1 K (-1.87 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Grant | A | 0.00 | 10,500 | 0 | 254,871 | 244.4 K to 254.9 K (+4.30 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | TOMBESI PAOLO | Chief Financial Off ... | Sell | S | 16.15 | 1,805 | 29,151 | 21,942 | 23.7 K to 21.9 K (-7.60 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | TOMBESI PAOLO | Chief Financial Off ... | Grant | A | 0.00 | 6,000 | 0 | 23,747 | 17.7 K to 23.7 K (+33.81 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 16.15 | 1,805 | 29,151 | 78,611 | 80.4 K to 78.6 K (-2.24 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 80,416 | 74.4 K to 80.4 K (+8.06 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Sell | S | 16.15 | 2,728 | 44,057 | 57,507 | 60.2 K to 57.5 K (-4.53 %) |
| Jun 30 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Grant | A | 0.00 | 6,000 | 0 | 60,235 | 54.2 K to 60.2 K (+11.06 %) |
| Jun 26 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | P | 16.03 | 62,019 | 994,165 | 82,601 | 20.6 K to 82.6 K (+301.33 %) |
| Jun 22 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 67,662 | 0 | 106,959 | 39.3 K to 107 K (+172.18 %) |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Option Exercise | M | 8.98 | 10,000 | 89,800 | 323,333 | |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | S | 22.00 | 10,000 | 220,000 | 244,371 | 254.4 K to 244.4 K (-3.93 %) |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | S | 22.00 | 10,000 | 220,000 | 254,371 | 264.4 K to 254.4 K (-3.78 %) |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Buy | M | 8.98 | 10,000 | 89,800 | 264,371 | 254.4 K to 264.4 K (+3.93 %) |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Option Exercise | M | 9.58 | 68,651 | 657,677 | 104,787 | |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Option Exercise | M | 12.45 | 2,289 | 28,498 | 107,577 | |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Option Exercise | M | 9.12 | 41,063 | 374,495 | 110,557 | |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Sell | S | 21.65 | 68,651 | 1,486,294 | 51,798 | 120.4 K to 51.8 K (-57.00 %) |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Buy | M | 9.58 | 68,651 | 657,677 | 120,449 | 51.8 K to 120.4 K (+132.54 %) |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Sell | S | 22.00 | 2,289 | 50,358 | 51,798 | 54.1 K to 51.8 K (-4.23 %) |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Buy | M | 12.45 | 2,289 | 28,498 | 54,087 | 51.8 K to 54.1 K (+4.42 %) |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Sell | S | 20.50 | 41,063 | 841,792 | 51,798 | 92.9 K to 51.8 K (-44.22 %) |
| Jun 22 2020 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Buy | M | 9.12 | 41,063 | 374,495 | 92,861 | 51.8 K to 92.9 K (+79.28 %) |
| Jun 02 2020 | EPZM | Epizyme, Inc. | Legorreta Pablo G. | Director | Option Exercise | A | 17.55 | 14,103 | 247,508 | 14,103 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | Giordano Michael F | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | Richon Victoria | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | Bogle Grant C. | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | POPS RICHARD F | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 |